Literature DB >> 11959206

Efficacy and safety of basiliximab in pediatric renal transplantation.

C García-Meseguer1, M Roldán, M Melgosa, A Alonso, A Peña, L Espìnosa, M Navarro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11959206     DOI： 10.1016/s0041-1345(01)02687-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.

Authors:  Agnieszka Swiatecka-Urban
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 2.  Basiliximab: a review of its use as induction therapy in renal transplantation.

Authors:  Therese M Chapman; Gillian M Keating
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Basiliximab induced non-cardiogenic pulmonary edema in two pediatric renal transplant recipients.

Authors:  Niamh Dolan; Mary Waldron; Marie O'Connell; Nick Eustace; Kevin Carson; Atif Awan
Journal:  Pediatr Nephrol       Date:  2009-08-01       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.